MedTrace Logo

Quantitative Fluorescent Guided Robotic Surgery for Cancer of the Gastroesophageal Junction

NCT04107623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-10-22

No results posted yet for this study

Summary

The investigators also aim to use our previously described quantifying method (q-ICG), to evaluate changes in gastric perfusion, during resection of cancer in the gastroesophageal junction (GEJ) and if a change in the operative technique influences microvascular flow in the gastroesophageal (GE) anastomosis.

Conditions

  • Stomach Neoplasms
  • Surgery

Interventions

DIAGNOSTIC_TEST

Indocyanine Green

Using Q-ICG perfusion of the remaining Gastric Conduit will be compared

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Jens TF Osterkamp, MD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2021-10-13
Completion
2021-10-13

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107623 on ClinicalTrials.gov